Progress and challenges in RNA interference therapy for Huntington disease

49Citations
Citations of this article
89Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Huntington disease is an incurable, dominant neurodegenerative disorder caused by polyglutamine repeat expansion in the huntingtin protein. Reducing mutant huntingtin expression may offer a treatment for Huntington disease. RNA interference has emerged as a powerful method to silence dominant disease genes. As such, it is being developed as a prospective Huntington disease therapy. Here I discuss the current progress and important remaining challenges of RNA interference therapy for Huntington disease. ©2009 American Medical Association. All rights reserved.

Cite

CITATION STYLE

APA

Harper, S. Q. (2009, August). Progress and challenges in RNA interference therapy for Huntington disease. Archives of Neurology. https://doi.org/10.1001/archneurol.2009.180

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free